France

Amazon.com plans to transition its air cargo fleet from Boeing 767 aircraft to Airbus A330 freighters, with Air Transport Services Group set to acquire and convert 30 Airbus A330 jets to support Amazon's air network. ATSG expects to begin operating the Airbus A330 cargo aircraft for Amazon in 2027 as part of the refreshed fleet. The switch gives Amazon access to larger, more modern cargo aircraft that can carry more volume per flight than the 767s they replace, potentially reshaping how the retailer positions inventory for Prime and marketplace orders, especially on longer domestic and transcontinental routes where aircraft range and payload matter most. The move marks a key shift in Amazon's air logistics strategy and lines up with the company's broader thesis of heavy capital spending on logistics and data centers as a trade off for efficiency and future return potential. The clearest proof point will arrive as ATSG starts flying the A330s in 2027, when Amazon discloses how much of its parcel volume flows through the new jets versus legacy aircraft and third party carriers, along with any commentary on unit costs per package or delivery speed.

TotalEnergies has entered into a partnership agreement with Global Infrastructure Partners, a part of BlackRock, covering its interests in some oil and gas infrastructure assets in Africa. Under the deal, GIP will make a US$1.8 billion capital contribution, and TotalEnergies will pay GIP a throughput-based tariff over a period of up to 15 years. Chief Financial Officer Jean-Pierre Sbraire said the agreement strengthens the company's relationship with GIP and crystallizes the value of some of its midstream infrastructure assets in Africa. TotalEnergies is a global integrated energy company with more than 100,000 employees active in about 120 countries.

Soitec announced the success of its offering of bonds settled in cash and/or convertible into new shares and/or exchangeable for existing shares, known as ORNANEs, due September 2033 for a nominal amount of €500 million. The bonds carry a fixed coupon of 0.5% per annum, were issued at 100% of their Principal Amount on September 25, 2026, and will be redeemed at par on September 25, 2033, with the conversion and exchange price set at €206.46, a 55% premium above the reference share price of €133.20. Soitec said it will use the net proceeds for general corporate purposes, which may include refinancing existing indebtedness and investments to support organic growth, and Chief Financial Officer Albin Jacquemont tied the placement to investor confidence in the company's Photonics-SOI technologies for next-generation AI infrastructure. Concurrently, certain members of the bank syndicate acting as joint bookrunners organized a placement of existing Soitec shares at €133.20 through an accelerated bookbuilding to facilitate hedging for certain bond subscribers, from which Soitec will receive no proceeds. The company agreed to a lock-up ending 90 calendar days after the Issue Date, and potential dilution from the offering would represent up to 6.3% of the outstanding share capital should Soitec decide to deliver only new shares upon exercise of the conversion and exchange right.

ENGIE North America announced renewable energy supply agreements that will provide up to 568 MW of renewable electricity for Oracle's growing operations in Texas. The power will come from a portfolio of wind energy resources serving the Electric Reliability Council of Texas market, part of ENGIE's roughly 12 GW of new renewable generation and battery storage capacity built across North America over the past six years. Anne-Laure Chassanite, Interim CEO of ENGIE North America, said the agreements reflect the strength of the company's portfolio and its ability to deliver customized energy solutions for customers expanding in Texas. Julia Robin, Head of Infrastructure Planning and Sourcing for Oracle Cloud Infrastructure, said the deals advance Oracle's goal to match 100 percent of its AI data center electricity use with carbon-free electricity by 2035 without shifting costs to Texas consumers. ENGIE North America, based in Houston, has approximately 12 GW of power generation in operation or under construction across North America, representing $11 billion of capital employed.

Innate Pharma said its first-half 2026 developments included closing a strategic partnership with Sobi for lacutamab, completing dose-escalation enrollment for IPH4502, and completing enrollment in the PACIFIC-9 phase III study of monalizumab. Chief Executive Officer Jonathan Dickinson said the Sobi transaction became effective on closing and included a $75 million upfront payment, which combined with a €30 million equity financing is expected to extend the company's projected cash runway through the end of the first quarter of 2028. The Sobi agreement also carries up to $40 million in near-term Sézary syndrome milestones, up to an additional $465 million tied to development-rights options and future regulatory and commercial milestones, and tiered double-digit royalties on future net sales. Innate has initiated the TELLOMAK-3 confirmatory phase III trial of lacutamab in cutaneous T-cell lymphoma, with the first patient expected in the first quarter of 2027, and plans to seek accelerated approval in Sézary syndrome in the second half of 2027. The company expects key clinical updates in the second half of 2026, including a PACIFIC-9 phase III readout for monalizumab and initial phase I data for IPH4502, an antibody-drug conjugate that has shown preliminary responses in several heavily pretreated solid-tumor populations.

Amundi has acquired a 9.9% economic interest in alternatives asset manager ICG in a deal worth about €620m, or $711.4m, following the long-term strategic and equity partnership the two firms agreed in November 2025. Under a 10-year arrangement tied to the deal, Amundi will serve as the sole global distributor in the wealth channel for ICG's evergreen products and certain other offerings, while ICG will be the exclusive supplier of those products to Amundi's distribution business. The agreement also covers the joint creation of new products aimed at wealth investors, with the first, centred on private equity secondaries, due to be introduced in the coming weeks. Amundi CEO Valérie Baudson said the partnership marks a significant step in the development of Amundi's private markets offering, and ICG CEO and chief investment officer Benoît Durteste said the deal is the first step in realising the commercial benefits of the collaboration.

Thales has announced the launch of HexaForce, its next-generation AI-enhanced multi-domain command and control system, purpose-built to support national sovereignty for NATO and allied nations. The system was successfully tested during the NATO CWIX 2026 exercise and is tailored for high-intensity warfare, supporting command requirements for over 100,000 personnel. HexaForce operates across land, air, sea, cyber, electromagnetic spectrum, space, and information operations, and harnesses the artificial intelligence capabilities of cortAIx, Thales' dedicated AI accelerator, which brings together 800 engineers and data scientists. Live trial phases are currently paving the way for full-scale deployment, targeting an increase in capacity from 100 to 1,000 targets processed per day. The solution draws on operational feedback from Artemis.IA, a data-centric platform deployed with the French Ministry of Armed Forces since 2023, and is already available.

Thai Airways is signalling continued profit growth in 2026, with Chai Eamsiri, Chief Executive Officer of Thai Airways International Public Company Limited, or THAI, revealing that the company expects full-year total revenue to potentially exceed 200 billion baht, after the first half of the year brought in nearly 100 billion baht, or approximately 99 billion baht, along with a profit of about 12 billion baht. At the same time, its liquidity position remains a strength, with more than 120 billion baht in cash on hand, up from the second quarter. The company is pressing ahead with managing its fleet of 87 aircraft to capture opportunities from regional low-cost carriers facing liquidity constraints and cutting services on certain routes. It plans to add Boeing 787 aircraft to the fleet and to return one existing aircraft that has been refurbished and fitted with seats to service on medium-haul routes. In the Asian market, particularly China, India, and Vietnam, it is preparing to add Airbus A321 aircraft. On fuel price risk management, for the remainder of 2026 the company has already hedged more than 40%, and for 2027 it has hedged about 48%. Kittiphong Sansomboon, Chief Commercial Officer, said that in the winter flight schedule for 2026/2027, running from October 25, 2026 to March 27, 2027, Thai Airways will operate a total of 66 routes, launching a new Bangkok–Da Nang route with 14 flights per week starting December 1, 2026, while increasing frequency on the Bangkok–Vientiane and Bangkok–Yangon routes to 21 flights per week per route, Bangkok–Siem Reap to 7 flights per week, Bangkok–Amsterdam to 7 flights per week, Bangkok–Munich to 10 flights per week, Bangkok–Zurich to 11 flights per week, Bangkok–Paris to 14 flights per week, and resuming service on the Bangkok–Xiamen route with 4 flights per week.

Ramsay Santé Group unveiled "Connecting Care 2030," a new four-year strategic roadmap, at its 2026 Capital Markets Day in Paris. The plan targets revenue growth of between 2.0% and 3.0% in FY2027 with a stable EBITDA margin versus FY2026, and revenue growth of approximately 3.0% per annum with gradual EBITDA margin improvement by FY2029, alongside gross capex of about 4.0% of revenue on average over the FY2027 to FY2029 period. The group also targets continued deleveraging, with net debt to EBITDA on a pre-IFRS basis below 4.0x. The strategy rests on five pillars: strengthening the integrated and accessible healthcare offering, embracing digital transformation, active portfolio and contract management, continued cost initiatives, and accelerating profitable growth through new revenue streams. Separately, majority shareholder Ramsay Health Care, which holds 52.79% of Ramsay Santé Group, has announced its intention to distribute its entire stake to its own shareholders through an in-specie distribution expected in December of this year, and Ramsay Santé has applied for a foreign exempt listing on the Australian Securities Exchange through CHESS Depository Interests. Crédit Agricole Assurances, which holds 39.82% of the group, has reaffirmed its commitment as a long-term shareholder.

Swedish Orphan Biovitrum AB and Innate Pharma SA announced that their previously announced strategic partnership is now effective following the expiration of applicable antitrust waiting periods and completion of other conditions. The partnership, entered on the 10th of August 2026, enables initiation of the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T cell lymphoma, a key step toward filing for accelerated approval of lacutamab in Sézary syndrome, with the first patient expected in Q1 2027. Under the agreement, Innate will conduct the TELLOMAK-3 Phase 3 confirmatory trial to support a planned accelerated approval filing for Sézary syndrome, and the study will also support applications for full approvals in key jurisdictions in Sézary syndrome and mycosis fungoides. Sobi will receive exclusive global rights to commercialise lacutamab upon potential accelerated approval and will be eligible to assume full global development rights following positive Phase 3 results. Sobi will pay Innate Pharma USD 75 million upon the partnership becoming effective, and Innate will be eligible to receive up to a further USD 40 million in near-term development milestones connected to Sézary syndrome, up to USD 465 million related to the option for Sobi to get full development rights and to future regulatory and commercial milestones, plus tiered double-digit royalties on net sales.

A syndicate of ten banks will provide $22 billion in financing for chip purchases by Crux AI, a new cloud venture established by Blackstone and Google, a unit of Alphabet. People familiar with the matter disclosed this on the 16th. The banking group includes Goldman Sachs Group, Sumitomo Mitsui Banking Corporation, Barclays, BNP Paribas, and Bank of Nova Scotia, among others. Crux AI, which was formally launched last week, has secured an initial $5 billion investment from Blackstone, and will receive Google's proprietary TPU chips along with software and various services. The borrowed funds from the banking group will be used to purchase Google-made TPUs, and the loans are expected to be secured by the asset value of these chips and the customer contracts held by Crux AI. The banking group is seeking additional lenders to join in a syndication aimed at spreading risk, and the debt could potentially be refinanced in the future with long-term funding from institutional investors in the investment-grade corporate bond market.

Vallourec has secured the entire carbon-steel line pipe and external coating scope for Petrobras's Sepia 2 offshore development in Brazil's Santos Basin, covering roughly 130 kilometers of rigid risers and flowlines. The contract, awarded by Subsea7, represents more than 15,000 tonnes of carbon-steel seamless line pipe designed for highly corrosive environments, with Vallourec also applying thermal insulation coating through one integrated offer. Vallourec shares rose around 6% on the announcement. The pipes will be manufactured at Vallourec's Jeceaba plant in Minas Gerais, while the thermal insulation coating will be applied at its Serra facility in Espírito Santo. Sepia 2 sits around 280 kilometers off the Brazilian coast in ultra-deep water, with 15 wells connected to a new floating production, storage and offloading vessel at depths of roughly 2,170 meters. No financial value was disclosed, but the order adds to recent offshore wins including Petrobras-linked projects at Atapu and Búzios, and follows a 2025 agreement with Petrobras that could generate up to $1 billion of revenue from offshore OCTG products and services between 2026 and 2029.

TotalEnergies has entered into a three-year partnership with French AI company Mistral to develop AI models for oil and gas reservoir exploration and engineering, backed by an investment of more than €100m. The joint programme aims to improve the ability to integrate, process and interpret large volumes of geoscientific data, combining TotalEnergies' expertise in subsurface geoscience and reservoir engineering with Mistral's technological and scientific resources. The goal is to create AI models that generate multiple development scenarios for exploration opportunities, as well as optimise or extend the life of existing projects. The companies plan to use next-generation AI techniques including agentic AI to work with up to ten petaflops of data, alongside nearly a century of TotalEnergies' accumulated geoscience knowledge, and will set up a shared scientific laboratory bringing together TotalEnergies' subsurface specialists and Mistral's scientific and technical skills. TotalEnergies chairman and CEO Patrick Pouyanné said exploration and reservoir engineering are among the areas where artificial intelligence can create the greatest value, while Mistral co-founder and CEO Arthur Mensch said the project demonstrates the ability of its models to support complex industrial processes. Earlier this month, TotalEnergies completed an asset swap with Galp following an agreement reached in December 2025, acquiring a 40% operated interest in the PEL83 licence, which includes the Mopane discovery, in return for Galp receiving a 10% participating interest in the PEL56 licence, covering the Venus discovery, and a 9.39% participating interest in the PEL91 licence.

A series of agreements between US and Vietnamese companies in sectors including energy, technology, aviation and finance are expected to be announced next week to coincide with the New York visit of Vietnam's top leader, Communist Party General Secretary and State President To Lam. The plans were revealed by officials and documents obtained by Reuters. An internal planning document lists 29 agreements that could be announced at a business conference in New York on the 23rd, which Lam will also attend. The contents of the document are subject to change, and it does not set out the specific details of the planned agreements. US energy companies Murphy Oil and Chevron are expected to announce agreements with Vietnamese state oil and gas company PetroVietnam, while ExxonMobil is expected to announce an agreement with PetroVietnam Refinery and Petrochemical, Vietnam's second-largest refinery. Vietjet, Vietnam's largest private airline, is expected to announce it will lease up to 22 aircraft from four leasing companies, comprising 17 Boeing 737s and five Airbus A321neos. SpaceX is also set to announce an agreement to provide its Starlink satellite internet service to 120 Vietjet aircraft. The planning document also includes an agreement between US-based Meta and Vietnam's Ministry of Culture, and one between US semiconductor giant Qualcomm and Vietnamese telecom company VNPT. Visa, Mastercard and Citibank are also expected to announce agreements with partners in Vietnam's domestic financial and hospitality services sectors.

Airbus delivered the first A320neo assembled at its new plant in Tianjin, China, on September 16. The plant is a final assembly line, or FAL, for the A320 family and is Airbus's second aircraft assembly line in both China and the Asia-Pacific region. The recipient was China Eastern Airlines, which currently operates the largest Airbus fleet in China and took delivery of the A310, the first Airbus aircraft in China, in 1985. Philippe Mhun, Airbus Executive Vice President for Commercial Aircraft Programmes and Services, said the delivery underscores Airbus's long-term commitment to its partners in China and its confidence in the continued growth of China's civil aviation market. The second assembly line in China, which began operations in October 2025, will be a key driver in accelerating the global production rate of the A320 family toward the target of 75 aircraft per month, while adding flexibility and capacity to meet strong market demand.

French auto giant Renault and Chinese peer Geely Automobile announced on the 15th that they will invest a further 319 million euros in Brazil through their joint venture, strengthening their partnership in that market. With this new investment, the two companies' total investment in Brazil from 2025 to 2027 will reach 899 million euros. According to Renault, the agreement will allow Geely to use Renault's existing plants and dealership network, while Renault will be able to raise utilization at its assembly plants and add large vehicles to its lineup. Under the new investment plan, Renault will begin producing its flex-fuel-capable four-wheel-drive hybrid system, Hybrid E-Tech, in Brazil starting in 2027. In Brazil, rival Chinese electric vehicle giant BYD is steadily building a foothold with affordable EVs and plug-in hybrids.

The European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the experimental Lyme disease vaccine candidate from Pfizer and French biotech Valneva, and will now begin its official review. The filing rests on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older in high-incidence Lyme disease locations across the US, Canada, and Europe, which reported efficacy of over 70% in reducing confirmed Lyme disease cases with no safety issues detected. The statistical picture was less clean than the headline number: the first prespecified analysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%, while a second prespecified analysis showed 74.8% efficacy and did meet that threshold. Under the 2020 partnership and license agreement, Pfizer holds exclusive rights to produce and commercialize the vaccine if approved, with Valneva benefiting as development partner; Valneva says PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development. Pfizer shares were essentially flat on the news, and hedge fund ownership stood at 83 funds in the second quarter of 2026, unchanged from the first quarter, while Valneva's hedge fund exposure rose to 4 funds from 1. MAA validation means the application meets the standards for the EMA to begin evaluating it, not that approval is near or guaranteed, and formal reviews of this nature often take many months to complete.

Axa Chief Executive Officer Thomas Buberl said the insurer will prioritize efficiency and shareholder returns over acquisitions after raising its profitability and growth targets for the next three years. Speaking to Bloomberg Television, Buberl described the new plan as a continuation of the current one, under which all countries and all lines of business are now performing extremely well. He said the next phase centers on organic growth and leveraging that position to gain additional market share, while bolt-on deals will still be considered under the company's long-standing policy. Asked about risks to the outlook, including France's presidential election next year, Buberl said the insurance sector is driven by structural factors such as population growth, rising risk, longer longevity and questions around retirement and health. He added that short-term political uncertainty never does any good for business, but that nobody in France will change their medical or household insurance because of it.

TotalEnergies signed new exploration agreements to operate Angola's offshore Blocks 17/25 and 32/21 in the Lower Congo Basin, expanding its operated footprint in the country. The company also reported rapid first oil from its Acacia-5 discovery, using existing offshore infrastructure to move from find to output quickly. The two Angolan blocks add fresh optionality around future African upstream project volumes, with shared operatorship alongside ExxonMobil and Sonangol. TotalEnergies operates as a large integrated energy producer with a €176.8 billion market cap, spanning oil, biofuels, natural gas, low carbon hydrogen, renewables and electricity across Africa, Europe, the United States and beyond. The expansion deepens the group's dependence on steady project delivery and stable regulation in Africa even as it supports its strategy of redeploying capital into lower-cost, higher-return hydrocarbon projects.

GENFIT announced it will investigate nangibotide in a Phase 2 clinical trial for the treatment of Acute-on-Chronic Liver Failure, or ACLF, following its acquisition of the late-stage asset in summer 2026. The company expects to initiate a Phase 2a proof-of-concept study in the fourth quarter of 2026, with data readout targeted in 2027, and will disclose more details during The Liver Meeting in Denver in November 2026. Nangibotide has been evaluated in four clinical trials with more than 400 subjects exposed, and post-hoc analyses of Phase 2 trials in septic shock and COVID-19 showed multiple efficacy signals, including a statistically significant reduction in mortality in severe COVID-19 and significant improvements in SOFA score from baseline in septic shock, with no meaningful differences versus placebo in safety outcomes. GENFIT said the existing regulatory and CMC packages for nangibotide are well advanced to support rapid clinical development in ACLF. CEO Pascal Prigent said ACLF represents one of the most significant unmet needs in liver disease and that nangibotide could be a strategic fit for the company's ACLF portfolio.

TotalEnergies plans to invest $10 billion alongside its partners in Angola over the next five years to maintain and potentially increase its oil production there. The company currently produces around 450,000 barrels per day in Angola, making it the country's largest oil operator and accounting for more than 40% of its total output. The spending will cover existing operations, new exploration, and projects to replace production from Angola's aging offshore fields, including the $6 billion Kaminho development, which is expected to start producing oil in 2028. TotalEnergies has also signed agreements for two additional offshore blocks and recently announced a discovery in Block 17 that could add roughly 6,000 barrels per day. The company acknowledged that much of the $10 billion may be needed just to keep production from falling, and that major projects such as Kaminho will not begin producing until 2028, leaving returns dependent on oil prices and subject to potential delays.

Teva Pharmaceutical Industries said its "Pivot to Growth" strategy has entered its second phase, with management pointing to branded-medicine momentum, a stabilized generics business, an expanding biosimilars portfolio and a strengthened balance sheet. Speaking at a Morgan Stanley event, President and Chief Executive Officer Richard Francis said the strategy, launched in 2023, rests on four pillars: delivering on the growth engine, stepping up innovation, creating a generics powerhouse, and focusing the business and capital allocation. Francis said Teva has cut debt and secured investment-grade ratings from all three major agencies more than a year ahead of its projection, completed an oversubscribed refinancing in the prior week, and converted ADS shares into ordinary shares to broaden investor access. He reiterated confidence that AUSTEDO can eventually exceed $3 billion in sales, ahead of the prior $2.5 billion target, and said AJOVY is approaching the $1 billion threshold faster than expected, while UZEDY and long-acting olanzapine together represent a $1.5 billion to $2 billion opportunity. Teva has 11 biosimilars on the market and expects to add roughly nine more by the end of the decade, and Francis said the company is on track to exceed its $800 million biosimilars target for 2027 a year early. Chief Medical Officer Eric Hughes said the TL1A therapy duvakitug, developed with Sanofi for ulcerative colitis and Crohn's disease, showed the highest phase 2 results reported for the class, and that ecopipam, a first-in-class D1 antagonist for Tourette's disease, received priority review with a potential launch in the first half of 2027.

Morgan Stanley downgraded Stellantis to Underweight from Equal Weight and cut its price target to $5.20 from $8.00, sending the automaker's shares down more than 2% on Monday. The rating change came as part of a broader review of European automakers by analysts led by Javier Martinez de Olcoz Cerdan, who cited changes in Stellantis' inventories and incentives and said the product pipeline is lagging behind peers, potentially limiting the company's ability to reduce investment as cash generation declines. Morgan Stanley said Stellantis has the widest risk/reward skew in the sector, flagging refinancing as one potential risk, while asset disposals or changes to the United States-Mexico-Canada Agreement could affect its outlook in other scenarios. In the same review, Morgan Stanley upgraded Renault to Equal Weight from Underweight and raised its price target to €31 from €25, calling it the company with the largest increase in its estimates, and maintained Overweight ratings on Mercedes-Benz and BMW, lifting its Mercedes-Benz target to €59 from €58 and its BMW target to €76 from €74, with Mercedes-Benz remaining its preferred stock in the sector. Volkswagen's price target was raised to €89 from €77 with its Equal Weight rating maintained, Porsche stayed Underweight, and Morgan Stanley said it believes the cyclical margin bottom is behind us, raising its 2026 and 2027 estimates for the European automotive sector for the first time since April 2024, with forecasts now slightly above consensus.

SES announced the successful launch of its eleventh, twelfth and thirteenth O3b mPOWER satellites, completing its second-generation medium Earth orbit constellation. The three satellites lifted off at 2:49 pm local time aboard a SpaceX Falcon 9 rocket from Space Launch Complex 40 at Cape Canaveral Space Force Station. They join the 10 O3b mPOWER spacecraft already in operation, bringing the full constellation to 13 satellites offering services ranging from tens of Mbps to multiple gigabits per second of capacity to any site. CEO Adel Al-Saleh called the launch a defining milestone that reinforces SES's ability to deliver resilient, secure and scalable connectivity for governments, enterprises, cloud providers and mobility customers. The newly launched satellites are expected to become operational by mid-2027, expanding high-performance connectivity capacity in underserved and remote environments and advancing SES's next-generation MEO network strategy.

Alstom has signed contracts worth €1.2 billion with TransPennine Express for the supply and long-term maintenance of a new fleet of battery-electric trains, which will be Britain's first mainline battery-electric fleet. The agreements combine a rolling stock contract worth approximately €930 million for 29 five-car battery-electric multiple units with maintenance contracts valued at around €230 million, and the order will be booked in the second quarter of Alstom's fiscal year 2026/27. The trains will be designed, engineered, built and tested at Alstom's Derby Litchurch Lane Works, with manufacturing expected to begin in 2028 and delivery from 2032, supporting more than 350 highly skilled jobs in Derby and over 5,500 roles across Alstom's UK supply chain. The order marks the first deployment of Alstom's Adessia Stream platform in the UK, and Alstom will install charging infrastructure at Hull, Scarborough and Saltburn, a UK-first on the mainline network. The fleet, funded by rail investor Rock Rail, will replace part of TPE's existing Class 185 fleet on services connecting Liverpool, Manchester, York, Hull, Scarborough and Saltburn.